AURORA: Aiming to Understand the Molecular Aberrations in Metastatic Breast Cancer.
Condition(s):Metastatic Breast CancerLast Updated:January 18, 2023Suspended
Hide Studies Not Open or Pending
Condition(s):Metastatic Breast CancerLast Updated:January 18, 2023Suspended
Condition(s):Breast Cancer; Estrogen Receptor Positive Tumor; Menopause; Hormone AntagonistLast Updated:September 30, 2020Completed
Condition(s):Metastatic Breast CancerLast Updated:February 26, 2024Completed
Condition(s):Metastatic Breast CancerLast Updated:February 15, 2019Completed
Condition(s):Metastatic Breast CancerLast Updated:October 15, 2014Completed
Condition(s):Breast CancerLast Updated:January 3, 2020Completed
Condition(s):Metastatic BreastcancerLast Updated:June 1, 2023Completed
Condition(s):Breast CancerLast Updated:March 11, 2020Completed
Condition(s):Breast CancerLast Updated:July 19, 2012Terminated
Condition(s):ER-positive Breast Cancer; HER2-negative Breast Cancer; Stage IIB Breast Cancer; Stage III Breast CancerLast Updated:January 24, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.